DTaP/IPV/Hib+HepB vaccine (2025)
UK Health Security Agency · awarded 10 July 2024
£1
Award value
£1
1
Supplier
Recorded as a large business
31 Mar 2029
Runs until
from 1 Apr 2025
Who
| Buyer | UK Health Security Agency London |
|---|---|
| Supplier |
GLAXOSMITHKLINE UK LIMITED |
| Category | goods |
| Classification | Vaccines CPV 33651600 |
| Notice published | 25 July 2024 |
What it is for
A contract for the supply of DTaP/IPV/Hib+HepB vaccine, to be used as part of the national childhood immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
540 awards on file, worth £872.1m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jun 2026 | Live Attenuated Influenza vaccine 2026/2027 | UK Health Security Agency | ASTRAZENECA UK LIMITED | £225.4m |
| 18 Jan 2022 | Single Service Centre - HGS | UK Health Security Agency | HINDUJA GLOBAL SOLUTIONS UK LIMITED | £211.9m |
| 3 Dec 2025 | Select Item 1 UKHSA Trust Programme Delivery Partner | UK Health Security Agency | PA CONSULTING SERVICES LIMITED | £29.6m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
Everything UK Health Security Agency has awarded →
Other contracts won by this supplier
4 awards on file, worth £1.6bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |
| 10 Jul 2024 | DTaP/IPV/Hib+HepB vaccine (2025) | UK Health Security Agency | GLAXOSMITHKLINE UK LIMITED | £1 |